Arkema (AKE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Jan, 2026Strategic vision and portfolio
Aims to be a specialty materials leader, focusing on innovative and sustainable solutions for evolving customer needs.
Portfolio is 92% specialty materials, with balanced exposure across adhesives, advanced materials, and coating solutions.
Operates in 55 countries with 151 production sites and 17 R&D centers, supporting a global footprint.
High R&D intensity, with over 1,800 researchers and 216 new patent applications in 2023, mostly related to sustainability.
Sustainability and CSR commitments
Targets net-zero GHG emissions by 2050, with a 48.5% reduction by 2030 (Scopes 1+2) and 54% for Scope 3.
Aims for 65% of sales to contribute to the UN SDGs by 2030 and 90% of sales to undergo life cycle assessment.
Achieved a CDP A rating for climate change and MSCI A rating for ESG performance.
Ongoing biodiversity initiatives and decarbonization of the coating value chain, with new ISCC+ certifications.
Growth drivers and investments
Focuses on high-growth submarkets: green energy, electric mobility, advanced electronics, efficient buildings, and healthcare.
Expects sales to grow from €9.5bn in 2023 to ~€12bn in 2028, with targeted organic sales CAGR three times the group average in key submarkets.
Recent and upcoming investments (~€1.1bn CAPEX, €3bn combined EV) are nearly fully financed, with major projects in China, France, Singapore, and the US.
Recent acquisitions include Ashland Performance Adhesives, PI Advanced Materials, and Dow's flexible packaging laminating adhesives.
Latest events from Arkema
- EBITDA dropped but cash flow and cost savings were strong, with Asia and growth markets outperforming.AKE
Q4 202526 Feb 2026 - Q2 2024 EBITDA rose 8.2% on 3.8% sales growth, with guidance raised for the year.AKE
Q2 20242 Feb 2026 - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 202416 Jan 2026 - Ambitious growth, innovation, and sustainability drive strong specialty materials performance.AKE
BNPP Exane CEO Conference Presentation13 Jan 2026 - Q3 2024 saw higher sales and EBITDA, with strong specialty materials growth and sustainability focus.AKE
BOFA European Materials Conference 2024 Presentation13 Jan 2026 - Strong specialty materials growth, resilient margins, and major investments drive future expansion.AKE
Morgan Stanley Chemicals Cannonball Run Field Trip Presentation13 Jan 2026 - EBITDA margin held at 15.2% in Q2 2025, with cost-saving targets doubled for the year.AKE
Q2 202513 Jan 2026 - 2024 EBITDA rose 2.1% to €1.53bn, led by Specialty Materials and Asian growth.AKE
Q4 202418 Dec 2025 - Sales growth in Asia offset weak Western demand, but profits fell; 2025 outlook stable.AKE
Q1 202518 Nov 2025